Medtronic PLC MDT
88.64
0.13
0.15%
as of 25 Sep
- Market cap
- $112.2B
- P/E
- 21.7×
Follow MDT
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Medtronic PLC (MDT) Gross margin
Medtronic PLC's gross margin over the twelve months to 31 July 2026 was 65.0%, down 0.0 percentage points from fiscal 2026 (65.0%). Over the past ten years it has ranged from 65.0% (fiscal 2026) to 70.0% (fiscal 2019) — the current reading is the lowest in ten years. That is above the Medical Devices industry median of 56.0% and above the Healthcare sector median of 53.7%.
Gross margin, annual
Annual
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2026 | 65.0% | (0.30) |
| FY2025 | 65.3% | (0.02) |
| FY2024 | 65.3% | (0.33) |
| FY2023 | 65.7% | (2.31) |
| FY2022 | 68.0% | 2.79 |
| FY2021 | 65.2% | (2.22) |
| FY2020 | 67.4% | (2.63) |
| FY2019 | 70.0% | 0.31 |
| FY2018 | 69.7% | 1.01 |
| FY2017 | 68.7% | 0.43 |
Quarterly
| Period | Gross margin | Change (points) |
|---|---|---|
| Jul 2026 | 65.0% | (0.36) |
| Apr 2026 | 65.4% | 1.52 |
| Jan 2026 | 63.8% | (2.01) |
| Oct 2025 | 65.8% | 0.82 |
| 43 more quarters | Free account |
Against its own ten years
Low 65.0%
High 70.0%
Ten-year median
67.7%
Current reading's percentile
8
Gross margin against peers
| Company | Gross margin |
|---|---|
| EW Edwards Lifesciences Corporation compare | 77.8% |
| BSX Boston Scientific Corporation compare | 69.9% |
| MDT Medtronic PLC | 65.0% |
| SYK Stryker Corporation compare | 65.0% |
| DXCM DexCom, Inc. compare | 62.5% |
| ABT Abbott Laboratories compare | 56.6% |
| PHG Koninklijke Philips N.V. compare | 45.9% |
| STE STERIS plc compare | 44.4% |
| GEHC GE HealthCare Technologies Inc. compare | 39.5% |
| Medical Devices industry median | 56.0% |
| Healthcare sector median | 53.7% |
| Market median | 46.3% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on MDT
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement